The key factors driving companion diagnostics market growth include increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support companion diagnostics market. Report analyzes companion diagnostics market by product & service, technology, indication, end user, & region.
- Agency -.
Complete report on Companion Diagnostics Market spread across 170 pages, Profiling 15 Companies and Supported with 105 Tables and 37 Figures is now available at www.rnrmarketresearch.com/companion-diagnostics-market-bytechnology-polymerase-chain-reaction-in-situ-hybridization-immunohistochemistry-application-breast-lung-cancer-by-end-user-pharmaceutical-companies-referenc-market-report.html .
The global Companion Diagnostics Market is projected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development.
Stakeholders of Companion Diagnostics Market
- Pharmaceutical and biotechnology companies
- Diagnostic manufacturers
- Research laboratories and academic institutes
- Research and development (R&D) companies
- Clinical research organizations (CROs)
The growth of companion diagnostics market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across globe, and increasing collaborations and partnerships for companion diagnostics test development.
- Agency -.
“The pharmaceutical & biopharmaceutical companies segment expected to grow at fastest CAGR”. On basis of end user, pharmaceutical & biopharmaceutical companies segment accounted for the largest share of market in 2016.
This end-user segment also expected to register highest CAGR during forecast period. Large share & growth of this market can be attributed to increasing and significant application of companion diagnostics in drug development process.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–45%, Tier 2–34%, and Tier 3–21%
- By Designation– C-level–14%, Director Level–10%, and Others–76%
- By Region – North America–40%, Europe–32%, Asia-Pacific–20%, and RoW–8%
Some of the major companion diagnostics market players in the companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc.
(U.S.), and QIAGEN N.V. (Netherlands) dominated the global companion diagnostics market. Some of the other players competing in this market are Thermo Fisher Scientific Inc.
(U.S.), Abbott Laboratories, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Danaher Corporation (U.S.), Almac Group (U.S.), and Sysmex Corporation (Japan).
2 Market Ranking Analysis
3 Competitive Leadership Mapping
4 Visionary Leaders
6 Dynamic Differentiators
7 Emerging Companies
8 Competitive Benchmarking
9 Strength of Product Portfolio
10 Business Strategy Excellence
The companion diagnostics report analyzes and aims at estimating market size and future growth potential of this market based on various segments such as product and service, type of medical device, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: